Cardiomyopathies: focus on cardiovascular magnetic resonance.
Cardiomyopathies (CMPs) are a group of often inherited diseases characterised by abnormalities and associated dysfunction of heart muscle. In the past decade, cardiovascular magnetic resonance (CMR) has emerged as a powerful tool in their assessment, providing data that are complementary to other aspects of clinical evaluation. Key advantages of CMR are three-dimensional visualisation of the heart and its relationship to thoracic structures; gold-standard quantification of cardiac volumes and function, which can safely be repeated over time (no ionising radiation is involved); and tissue characterisation to detect focal scar and fatty infiltration. This paper reviews the role of CMR in the clinical assessment of patients with CMPs.
The Heart Hospital Imaging Centre, University College London Hospitals Trust, 16 Westmoreland Street, London, UK.
G
G
Quarta
D M
DM
Sado
J C
JC
Moon
D019571:Arrhythmogenic Right Ventricular Dysplasia / Q000175:diagnosis; D009202:Cardiomyopathies / Q000175:diagnosis*; D002311:Cardiomyopathy, Dilated / Q000175:diagnosis; D002313:Cardiomyopathy, Restrictive / Q000175:diagnosis; D003287:Contrast Media; D003331:Coronary Vessels / Q000503:physiopathology; D006801:Humans; D007511:Ischemia / Q000175:diagnosis; D008279:Magnetic Resonance Imaging / Q000379:methods*; D054549:Takotsubo Cardiomyopathy / Q000175:diagnosis; D016277:Ventricular Function, Left / Q000502:physiology
D003287:Contrast Media